首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1672694

次世代定序仪市场按产品类型、序列类型、应用、最终用户和地区划分

Next Generation Sequencing Market, By Product Type, By Sequencing Type, By Application, By End User, By Geography

出版日期: 2025年02月12日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球次世代定序仪市场规模预估为 189.4 亿美元，预计到 2032 年将达到 494.9 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 14.7%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	189.4亿美元
效能资料	2020-2024	预测期	2025-2032
预测期：2025 年至 2032 年复合年增长率	14.70％	2032 年金额预测	494.9亿美元

市场占有率。

新一代定序（NGS）是一种高通量DNA定序技术，与第一代桑格定序相比，该技术大幅降低了DNA定序的成本，并提高了速度和通量。 NGS 使研究人员能够对整个基因组进行定序，并大规模分析基因活动和表现的模式。自 2005 年发现以来，NGS 平台取得了长足的进步，能够一次对数千到数百万个 DNA 片段进行定序。这种大规模平行定序使得基因组学的全面表征和发现成为可能，彻底改变了生物和生物医学研究。 NGS 正在应用于多个领域，包括遗传学、肿瘤学、药物基因组学和个人化医疗。

市场动态：

全球次世代定序仪市场的成长受到一系列疾病领域基因组学和精准医疗应用不断扩大的推动。癌症发病率的上升和对药物基因组学的日益关注正在推动临床诊断和监测对 NGS 平台的需求。基因组学研究活动的成长、定序成本的持续下降以及可携式和易于使用的定序仪器的采用也在推动市场的成长。然而，由于NGS产生的资料量庞大以及生物资讯学知识有限，资料管理和分析问题仍然是一个挑战。另一方面，单细胞应用程式和云端基础的NGS资料管理解决方案的开发带来了丰厚的成长机会。

研究的主要特点

本报告对全球次世代定序仪市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、财务业绩和策略等参数，对全球次世代定序仪市场的主要企业进行了概述。
本报告的见解有望使负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球次世代定序仪市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员可以透过全球次世代定序仪市场分析中使用的各种策略矩阵来促进他们的决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 18.94 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	14.70%	2032 Value Projection:	USD 49.49 Bn

Next Generation Sequencing (NGS) refers to the high-throughput DNA sequencing technologies that have substantially decreased the cost and increased the speed and throughput of DNA sequencing as compared to the first-generation Sanger sequencing. NGS allows researchers to sequence entire genomes, as well as to analyze the patterns of gene activity or expression on a large scale. Since its discovery in 2005, there have been tremendous improvements in NGS platforms which has enabled the sequencing of thousands to millions of DNA fragments in a single run. This massively parallel sequencing has revolutionized biological and biomedical research by allowing comprehensive characterization and discovery in genomic research. NGS finds applications across various fields including genetics, oncology, pharmacogenomics and personalized medicine.

Market Dynamics:

The global next generation sequencing market growth is driven by growing applications of genomics and precision medicine across various diseases. Rising prevalence of cancer and growing focus on pharmacogenomics is fueling the demand for NGS platforms in clinical diagnosis and monitoring. Growing genomics research activities, coupled with continuous decline in sequencing costs and introduction of portable and user-friendly sequencing instruments is also boosting the market growth. However, data management and analysis issues due to the massive amount of data generated from NGS, and limited bioinformatics knowledge remains a challenge. Meanwhile, developments in single-cell applications and cloud-based solutions for NGS data management presents lucrative growth opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global next generation sequencing market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global next generation sequencing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Thermo Fisher Scientific Inc., Agilent Technologies Inc, bioMerieux SA, F. Hoffmann-La Roche Ltd, QIAGEN, Illumina Inc., Oxford Nanopore Technologies plc., BGI, PerkinElmer Genomics, Bio-Rad Laboratories Inc., Pacific Biosciences, 10x Genomics, Promega Corporation, Macrogen Inc., Eurofins Scientific, DNASTAR Inc., and CD Genomics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global next generation sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global next generation sequencing market.

Market Segmentation

Product Type:
- Instruments
- Reagents & Consumables
Sequencing Type:
- Whole Genome Sequencing
- Whole Exome Sequencing
- RNA Sequencing
- Targeted Re-sequencing
- Others
Application:
- Drug Discovery
- Personalized Medicine
- Genetic Screening
- Diagnostics
- Others
End User:
- Hospitals & Clinics
- Academic & Research Institutes
- Biopharmaceutical Companies
- Clinical Laboratories
- Others
Regional:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc
- bioMerieux SA
- Hoffmann-La Roche Ltd
- QIAGEN
- Illumina Inc.
- Oxford Nanopore Technologies plc.
- BGI
- PerkinElmer Genomics
- Bio-Rad Laboratories Inc.
- Pacific Biosciences
- 10x Genomics
- Promega Corporation
- Macrogen Inc.
- Eurofins Scientific
- DNASTAR Inc.
- CD Genomics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Sequencing Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pricing Analysis
PEST Analysis

4. Global Next Generation Sequencing Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Next Generation Sequencing Market, By Product Type, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Instruments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Reagents & Consumables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Next Generation Sequencing Market, By Sequencing Type, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Whole Genome Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Whole Exome Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
RNA Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Targeted Re-sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Next Generation Sequencing Market, By Application, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Drug Discovery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Personalized Medicine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Genetic Screening
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Global Next Generation Sequencing Market, By End User, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Biopharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Clinical Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Global Next Generation Sequencing Market, By Region, 2020 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  - UK
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
Africa

10. Competitive Landscape

Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Agilent Technologies, Inc
bioMerieux SA
F. Hoffmann-La Roche Ltd
QIAGEN
Illumina, Inc.
Oxford Nanopore Technologies plc.
BGI
PerkinElmer Genomics
Bio-Rad Laboratories Inc.
Pacific Biosciences
10x Genomics
Promega Corporation
Macrogen Inc.
Eurofins Scientific
DNASTAR Inc.
CD Genomics

11. Analyst View

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

次世代定序仪市场按产品类型、序列类型、应用、最终用户和地区划分